Cardiovascular disease prevention

and pathways － ER 12: CVD prevention in populations: lessons from other countries － ER 13: Will CVD prevention widen health inequalities? • NICE's guideline on overweight and obesity management: CG43 Full guideline, section 3 - prevention: evidence statements and reviews: － (1) Section 7.4.1.3 Evidence of corroboration － (2) Evidence statement 5, Section 12 Prevention evidence summary: broader community interventions (Community 2) － (3) Evidence statement 6, Section 12 Prevention evidence summary: broader community interventions (Community 2) － (4) Evidence statement 2, Section 10 Prevention evidence summary: broader community interventions (Community 2) Cost-effectiveness evidence The economic analysis consisted of a review of economic evaluations and a cost- effectiveness analysis. • 'Prevention of cardiovascular disease at population level (question 1; cost- effectiveness)' • 'Prevention of cardiovascular disease at population level: modelling strategies for primary prevention of cardiovascular disease'. Some primary prevention programmes involving education, mass media and screening with a general population were found to be effective and cost effective. They may reduce some of the risk factors for CVD, including changing behaviours which increase the risk. However, when the findings from all programmes were summarised, the overall effect on health outcomes was uncertain. In addition, as these programmes were
